As previous reports have proved that CD44 can be repressed by p53, and p53 can be degraded by MDM2 [10, 35, 51], our finding that MDM2 signaling could regulate CD44 expression reveals a new mechanism that connects MDM2 with CD44 in tumor collective detachment. The gene discussed is CD44; the disease is neoplasm.